Skip to main content
SpringerLink
Log in

Can a phone call be more effective than an intrathecal implanted pump?

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brogan SE, Winter NB (2011) Patient-controlled intrathecal analgesia for the management of breakthrough cancer pain: a retrospective review and commentary. Pain Med 12:1758–1768

    Article  PubMed  Google Scholar 

  2. Bruera E, Hui D (2010) Spinal analgesia: where is the evidence? Support Care Cancer 18:1237

    Article  PubMed  Google Scholar 

  3. Deer T, Smith H, Burton A et al (2011) Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Phys 14:E283–E312

    Google Scholar 

  4. Mercadante S, Agnello A, Armata MG, Pumo S (1997) The inappropriate use of the epidural route in cancer pain. J Pain Symptom Manage 13:233–237

    Article  PubMed  CAS  Google Scholar 

  5. Kalso E, Heiskanen T, Rantio M, Rosenberg PH, Vainio A (1996) Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study. Pain 67:443–449

    Article  PubMed  CAS  Google Scholar 

  6. Mao JR, Price DD, Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259–274

    Article  PubMed  CAS  Google Scholar 

  7. Mercadante S (2004) Re: Rauck et al. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain 5:138–139

    Article  PubMed  Google Scholar 

  8. Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S (2005) Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage 30:485–491

    Article  PubMed  CAS  Google Scholar 

  9. Mercadante S, Ferrera P, Villari P, Arcuri E (2005) Local anesthetics for breakthrough pain in patients receiving intrathecal treatment for cancer pain management. Anesth Analg 100:1540

    Article  PubMed  Google Scholar 

  10. Mercadante S, Intravaia G, Villari P, Ferrera P, Riina S, David F, Mangione S (2007) Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain 23:793–798

    Article  PubMed  Google Scholar 

  11. Mercadante S, Porzio G, Gebbia V (2012) Spinal analgesia for advanced cancer patients: an update. Crit Rev Oncol Hematol 82:227–232

    Article  PubMed  Google Scholar 

  12. Rauck R, Cherry D, Boyer M, Kosek P, Dunn J, Alo K (2003) Long-term intrathecal opioid therapy with a patient-activated implanted delivery system for the treatment of refractory cancer pain. J Pain 4:441–447

    Article  PubMed  CAS  Google Scholar 

  13. Reddy A, Hui D, Bruera E (2012) A successful palliative care intervention for cancer pain refractory to intrathecal analgesia. J Pain Symptom Manage 44(1):124–130

    Article  PubMed  Google Scholar 

  14. Smith TJ, Staats PS, Deer T et al (2002) Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management of refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 20:4040–4049

    Article  PubMed  CAS  Google Scholar 

  15. Yennurajalingam S, Dev R, Walker PW, Reddy SK, Bruera E (2010) Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases. J Pain Symptom Manage 39:930–935

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest to declare. Authors have full control of data.

Author information

Authors and Affiliations

  1. Anesthesia and Intensive Care Unit and Pain Relief and Supportive Care Unit, La Maddalena Cancer Center, Via San Lorenzo 312, 90146, Palermo, Italy

    Sebastiano Mercadante

  2. Department of Palliative Medicine, University of Palermo, Palermo, Italy

    Sebastiano Mercadante

  3. Hospice, Azienda Sanitaria Provinciale, Messina, Italy

    Patrizia Giardina

Authors
  1. Sebastiano Mercadante
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrizia Giardina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastiano Mercadante.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mercadante, S., Giardina, P. Can a phone call be more effective than an intrathecal implanted pump?. Support Care Cancer 21, 1213–1215 (2013). https://doi.org/10.1007/s00520-012-1665-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-012-1665-7

Keywords

Search

Navigation